Hypercholesterolaemia and treatment with statins do not alter L-arginine-induced changes of renal haemodynamics

Background. Hypercholesterolaemia has been found to impair endothelial function in the systemic and coronary circulations and lipid-lowering therapy with statins has been shown to improve this abnormality. Methods. We examined the impact of hypercholesterolaemia on L-arginine-induced renal vascular relaxation by a cross-sectional study, and the effects of lipid-lowering therapy by a double-blind, randomized, placebo-controlled study. Using constant infusion input clearance technique (PAH and inutin respectively), changes of renal plasma flow (RPF) and glomerular filtration rate (GFR) in response to intravenous infusions of L-arginine (100 mg/kg/30 min and 500 mg/kg/30 min) were studied in 21 hypercholesterolaemic humans (age 57 ± 9 years, LDL-cholesterol 211 ± 35 mg/dl) and in 20 young healthy (age 26 ± 2 years, LDL-cholesterol 90 ± 27 mg/dl) and 20 older healthy age-matched control individuals (age 50 ± 8 years, LDL-cholesterol 106 ± 20 mg/dl). In addition, changes of blood pressure, heart rate, urinary excretion of sodium, and cyclic guanosine monophosphate were measured. Patients were analysed before and after 3 months treatment with either fluvastatin (40 mg twice daily, n = 11) or placebo (n = 10). Results. In hypercholesterolaemic patients, L-arginine increased RPF and GFR (P<0.01) and urinary excretion of sodium (P<0.05) in a dose-dependent manner. Interestingly, changes were similar between the hypercholesterolaemic patients and the young and the age-matched control individuals (RPF 100 mg/kg/30 min, 40 ± 51 ml/min vs 40 ± 52 ml/min, P = NS; ΔRPF 500mg/kg/30min, 114±85ml/min vs 130±78 ml/min, P = NS). L-arginine significantly lowered systemic arterial pressure and increased heart rate in all groups. Despite significant reductions in LDL-cholesterol levels (291±35 mg/dl vs 213±30 mg/dl, P < 0.001), treatment with fluvastatin did not alter the renal haemodynamic response pattern to L-arginine infusion when compared to baseline values and to those with placebo. Conclusion. In contrast to studies performed in the vasculature of the human forearm or the coronary circulation, our results suggest that hypercholesterolaemia is not associated with an impaired L-arginine-induced renal vascular relaxation.